In the fields of medicine, biotechnology and pharmacology,听drug discovery听is the process by which new candidate medications are discovered. Historically,听drugs听were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
The global market for Drug Discovery Services was estimated to be worth US$ 17840 million in 2023 and is forecast to a readjusted size of US$ 34250 million by 2030 with a CAGR of 11.1% during the forecast period 2024-2030
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Discovery Services by region & country, by Type, and by Application.
The Drug Discovery Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Services.
Market Segmentation
By Company
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type:
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Segment by Application
Pharmaceutical Companies
Other
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Discovery Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Discovery Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Discovery Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Drug Discovery Services Product Introduction
1.2 Global Drug Discovery Services Market Size Forecast
1.3 Drug Discovery Services Market Trends & Drivers
1.3.1 Drug Discovery Services Industry Trends
1.3.2 Drug Discovery Services Market Drivers & Opportunity
1.3.3 Drug Discovery Services Market Challenges
1.3.4 Drug Discovery Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Discovery Services Players Revenue Ranking (2023)
2.2 Global Drug Discovery Services Revenue by Company (2019-2024)
2.3 Key Companies Drug Discovery Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Discovery Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Discovery Services
2.6 Drug Discovery Services Market Competitive Analysis
2.6.1 Drug Discovery Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Discovery Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemical Services
3.1.2 Biological Services
3.1.3 Lead Optimization
3.1.4 Lead Identification and Screening
3.2 Global Drug Discovery Services Sales Value by Type
3.2.1 Global Drug Discovery Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Discovery Services Sales Value, by Type (2019-2030)
3.2.3 Global Drug Discovery Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Companies
4.1.2 Other
4.2 Global Drug Discovery Services Sales Value by Application
4.2.1 Global Drug Discovery Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Discovery Services Sales Value, by Application (2019-2030)
4.2.3 Global Drug Discovery Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Discovery Services Sales Value by Region
5.1.1 Global Drug Discovery Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Discovery Services Sales Value by Region (2019-2024)
5.1.3 Global Drug Discovery Services Sales Value by Region (2025-2030)
5.1.4 Global Drug Discovery Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Discovery Services Sales Value, 2019-2030
5.2.2 North America Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Discovery Services Sales Value, 2019-2030
5.3.2 Europe Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Discovery Services Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Discovery Services Sales Value, 2019-2030
5.5.2 South America Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Discovery Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Discovery Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Discovery Services Sales Value
6.3 United States
6.3.1 United States Drug Discovery Services Sales Value, 2019-2030
6.3.2 United States Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Discovery Services Sales Value, 2019-2030
6.4.2 Europe Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Discovery Services Sales Value, 2019-2030
6.5.2 China Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Discovery Services Sales Value, 2019-2030
6.6.2 Japan Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Discovery Services Sales Value, 2019-2030
6.7.2 South Korea Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Discovery Services Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Discovery Services Sales Value, 2019-2030
6.9.2 India Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Discovery Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IQVIA
7.1.1 IQVIA Profile
7.1.2 IQVIA Main Business
7.1.3 IQVIA Drug Discovery Services Products, Services and Solutions
7.1.4 IQVIA Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.1.5 IQVIA Recent Developments
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Profile
7.2.2 Charles River Laboratories Main Business
7.2.3 Charles River Laboratories Drug Discovery Services Products, Services and Solutions
7.2.4 Charles River Laboratories Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.2.5 Charles River Laboratories Recent Developments
7.3 Aptuit
7.3.1 Aptuit Profile
7.3.2 Aptuit Main Business
7.3.3 Aptuit Drug Discovery Services Products, Services and Solutions
7.3.4 Aptuit Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.3.5 Evotec Recent Developments
7.4 Evotec
7.4.1 Evotec Profile
7.4.2 Evotec Main Business
7.4.3 Evotec Drug Discovery Services Products, Services and Solutions
7.4.4 Evotec Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.4.5 Evotec Recent Developments
7.5 GenScript
7.5.1 GenScript Profile
7.5.2 GenScript Main Business
7.5.3 GenScript Drug Discovery Services Products, Services and Solutions
7.5.4 GenScript Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.5.5 GenScript Recent Developments
7.6 PPD
7.6.1 PPD Profile
7.6.2 PPD Main Business
7.6.3 PPD Drug Discovery Services Products, Services and Solutions
7.6.4 PPD Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.6.5 PPD Recent Developments
7.7 WuXi AppTec
7.7.1 WuXi AppTec Profile
7.7.2 WuXi AppTec Main Business
7.7.3 WuXi AppTec Drug Discovery Services Products, Services and Solutions
7.7.4 WuXi AppTec Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.7.5 WuXi AppTec Recent Developments
7.8 AMRI
7.8.1 AMRI Profile
7.8.2 AMRI Main Business
7.8.3 AMRI Drug Discovery Services Products, Services and Solutions
7.8.4 AMRI Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.8.5 AMRI Recent Developments
8 Industry Chain Analysis
8.1 Drug Discovery Services Industrial Chain
8.2 Drug Discovery Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Discovery Services Sales Model
8.5.2 Sales Channel
8.5.3 Drug Discovery Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
听
听
*If Applicable.
